Japan is adding the Product Information Offering Activities of Ethical Drugs Act to their pharma code of conduct. These new standards go into force effective October 1, 2019.
Watch on-demand to learn:
- How the regulations address product information, manufacturer responsibilities, and employee responsibilities
- What the implications are for social, digital, and mobile channels
- Why global companies should act quickly, instead of getting left behind
- How to take advantage of the business opportunity